Regulator makes record illicit weight loss medicine seizure

Officers from the Criminal Enforcement Unit (CEU) of the Medicines and Healthcare products Regulatory Agency (MHRA) have made a record seizure at an illicit weight loss medicine production facility.

(c) Towfiqu Barbhuiya/Unsplash

(c) Towfiqu Barbhuiya/Unsplash

The seizure of thousands retatrutide and tirzepatide pens with a street value of over £250,000 was made at an industrial estate on the outskirts of Northampton.

Secretary of state for health and social care, Wes Streeting, said: ‘This is a victory in the fight against the shameless criminals who are putting lives at risk by peddling dangerous and illegal weight loss jabs to make a quick buck. 

‘These unregulated products, made with no regard for safety or quality, posed a major risk to unwitting customers. 

"My message is clear: don't buy weight loss medications from unregulated sources. Talk to your GP, seek NHS advice, and don't line the pockets of criminals who don't care about your health. Safe, appropriate, licensed obesity drugs can greatly benefit those in need if taken under medical supervision, and I urge people to only purchase and use them with the approval and oversight of medics and pharmacists.'

Andy Morling, head of the MHRA's CEU, said:‘Taking out the first illicit weight loss medicine manufacturing facility found in the UK is a landmark result for the MHRA and a major blow to the illegal trade. These products are untested, unauthorised, and potentially deadly. By taking this organised criminal network out of operation and stopping tens of thousands of potentially fatal products from entering circulation, we've prevented a serious risk to public health.'

A partnership approach to weight loss medicines

A partnership approach to weight loss medicines

18 August 2026

GP registrar and councillor Dr Olly Scargill discusses the findings of his report, The GLP-1 Population Health Project, and says better partnership working b...

THE BIG INTERVIEW: Reasons for concern

By Lee Peart 14 August 2026

In an exclusive interview, health spokesperson for the Liberal Democrats, Helen Morgan explains her concerns about the Health Bill.

UK first in Europe to authorise weight loss drug

By Lee Peart 11 August 2026

The UK has become the first nation in Europe to authorise the orforglipron (Foundayo), GLP-1 tablet for weight management and type 2 diabetes.


Popular articles by Lee Peart